Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Pharmacokinetic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01359319
What this trial is testing

Safety and Pharmacokinetics of Sialic Acid Tables in Patients With Hereditary Inclusion Body Myopathy (HIBM)

Who this might be right for
Hereditary Inclusion Body Myopathy (HIBM)
Ultragenyx Pharmaceutical Inc 26
Early research (Phase 1)UnknownNCT01259219
What this trial is testing

Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra

Who this might be right for
Children With Confirmed HIV InfectionReceiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard DoseSuccessfully Completed TB Treatment in the Past 2 to 6 Weeks of Enrollment
Harriet Shezi Children's Clinic 40
Early research (Phase 1)Study completedNCT02904330
What this trial is testing

K1-70 - A Study in Subjects With Graves' Disease

Who this might be right for
Graves' Disease
AV7 Limited 18
Early research (Phase 1)UnknownNCT06049667
What this trial is testing

Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia (AML)
Nanjing Chia-tai Tianqing Pharmaceutical 72
Early research (Phase 1)Study completedNCT01571999
What this trial is testing

Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 17
Early research (Phase 1)Study completedNCT04456634
What this trial is testing

Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Ruxolitinib With Artemether-lumefantrine

Who this might be right for
Malaria
Medicines for Malaria Venture 8
Early research (Phase 1)Study completedNCT06135363
What this trial is testing

Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Guangzhou JOYO Pharma Co., Ltd 45
Early research (Phase 1)Study completedNCT00891709
What this trial is testing

LEO 29102 Single and Multiple Dose Study by Dermal Application

Who this might be right for
Atopic Dermatitis
LEO Pharma 64
Early research (Phase 1)Study completedNCT02374684
What this trial is testing

Tolerability, Safety and Pharmacokinetic Study Of Methosulide in Healthy Adult Subjects

Who this might be right for
Healthy
Hubei Biological Medicine Industrial Technology Institute Co., Ltd. 92
Early research (Phase 1)Study completedNCT00747526
What this trial is testing

Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive

Who this might be right for
Gastroesophageal Reflux Disease (GERD)
Janssen Research & Development, LLC 51
Early research (Phase 1)Study completedNCT03009214
What this trial is testing

A Safety and Pharmacokinetic Phase I/Ib Study of AMC303 in Patients With Solid Tumours

Who this might be right for
Malignant Solid Tumor
amcure GmbH 55
Early research (Phase 1)Study completedNCT00709254
What this trial is testing

Study of Single and Multiple Doses of Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Healthy Subjects

Who this might be right for
Healthy
YM BioSciences 12
Early research (Phase 1)Study completedNCT01893866
What this trial is testing

A Relative Bioavailability Study To Evaluate Safety, Tolerability And Pharmacokinetic Comparability Of Pegvisomant 1 X 30 Mg Vs 2 X 15 Mg Subcutaneously Administered In Healthy Subjects

Who this might be right for
Healthy Volunteers
Pfizer 17
Testing effectiveness (Phase 2)UnknownNCT06590194
What this trial is testing

PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Suzhou Puhe Pharmaceutical Technology Co., LTD 96
Testing effectiveness (Phase 2)Looking for participantsNCT06459973
What this trial is testing

A Clinical Study of YL205 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd. 252
Early research (Phase 1)Study completedNCT02492737
What this trial is testing

Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic SyndromeHematologic Malignancies
Agios Pharmaceuticals, Inc. 46
Early research (Phase 1)UnknownNCT04494373
What this trial is testing

Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults

Who this might be right for
Bone Metastasis From Solid Tumors
Jiangsu Hansoh Pharmaceutical Co., Ltd. 154
Early research (Phase 1)Not Yet RecruitingNCT07364851
What this trial is testing

Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers

Who this might be right for
Healthy Adult Volunteer
Daewon Pharmaceutical Co., Ltd. 38
Early research (Phase 1)Study completedNCT05436912
What this trial is testing

Effects of Selpercatinib in Hepatically Impaired Participants and Healthy Participants

Who this might be right for
HealthyHepatic Impairment
Eli Lilly and Company 36
Early research (Phase 1)Study completedNCT00569140
What this trial is testing

A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 18
Next Page